Rational design of peptide agonists of cell-surface receptors

Trends in Pharmacological Sciences

Volumn 21, Issue 1, 2000, Pages 9-10

  Taylor, Simeon I ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE RECEPTOR; ERYTHROPOIETIN RECEPTOR; INSULIN; INSULIN RECEPTOR; JANUS KINASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE DK (61-85); RECEPTOR BLOCKING AGENT; SOMATOMEDIN C RECEPTOR; STAT5 PROTEIN; SYNTHETIC PEPTIDE; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; DIMERIZATION; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PRIORITY JOURNAL;

EID: 0033964165     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-6147(99)01414-5     Document Type: Short Survey

References (8)

1. Naranda T.et al. A peptide derived from an extracellular domain selectively inhibits receptor internalization: target sequences on insulin and insulin-like growth factor 1 receptors. Proc. Natl. Acad. Sci. U. S. A. 94:1997;11692-11697.
2. Naranda T.et al. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7569-7574.
3. Hansen T.et al. Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens. Proc. Natl. Acad. Sci. U. S. A. 86:1989;3123-3126.
4. Stagsted J.et al. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen. Cell. 62:1990;297-307.
5. Stagsted J.et al. Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide. J. Pharmacol. Exp. Ther. 267:1993;997-1001.
6. Olsson L.et al. Regulation of receptor internalization by the major histocompatibility complex class I molecule. Proc. Natl. Acad. Sci. U. S. A. 91:1994;9086-9090.
7. de Vos A.M.et al. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:1992;306-312.
8. Syed R.S.et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature. 395:1998;511-516.